<DOC>
	<DOCNO>NCT01397578</DOCNO>
	<brief_summary>This Phase II , randomize , double-blind , parallel-group , placebo-controlled study evaluate effect MABT5102A brain amyloid burden ( assess amyloid PET image ) biomarkers patient mild moderate Alzheimer 's disease .</brief_summary>
	<brief_title>A Study Evaluate Impact MABT5102A Brain Amyloid Load Related Biomarkers Patients With Mild Moderate Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Diagnosis probable AD accord National Institute Neurological Communicative Disorders Stroke Alzheimer 's Disease Related Disorder Association ( NINCDSADRDA ) criteria MiniMental State Examination ( MMSE ) score 1826 point screen Geriatric Depression Scale ( GDS15 ) score &lt; 6 Completion 6 year education ( good work history consistent exclusion mental retardation pervasive developmental disorder ) For patient currently receive treatment approve AD treatment ( AChE inhibitor memantine ) : Treatment initiate continue least last 3 month prior randomization , stable dose least last 2 month prior randomization Severe unstable medical condition , opinion investigator Sponsor , would interfere patient 's ability complete study assessment would require equivalent institutional hospital care History presence clinically evident vascular disease potentially affect brain ( e.g. , stroke , clinically significant carotid vertebral stenosis plaque , aortic aneurysm , intracranial aneurysm , cerebral hemorrhage , arteriovenous malformation ) History severe , clinically significant ( persistent neurologic deficit structural brain damage ) central nervous system trauma ( e.g. , cerebral contusion ) Hospitalization within 4 week prior screen Previous treatment MABT5102A therapeutic target Abeta Treatment biologic therapy within 5 halflives 3 month prior screen , whichever longer , exception routinely recommend vaccination , allow</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>